The following is a summary of the Tecsys Inc. (TCYSF) Q4 2024 Earnings Call Transcript:

Financial Performance:

• Tecsys reported record quarterly revenue of CAD 44 million in Q4, an increase of 7% year-over-year.

• For the fiscal year 2024, total revenue was CAD 171.2 million, up 12% compared to the previous year.

• SaaS revenue for fiscal 2024 was CAD 51.9 million, representing a 39% increase year-over-year.

• Gross margin for Q4 improved to 47% from 45% in the same period last year.

• Net profit for the quarter was relatively flat at CAD 259,000.

Business Progress:

• Tecsys achieved its highest quarterly revenue and SaaS bookings in the company's history during Q4.

• Major initiatives include gaining traction with the consolidated pharmacy service center (CPSC) model and expanding their healthcare sector offering.

• Partnerships influence 26% of deals, and new logos were half partner-influenced with 26% influence in total deals.

• Continued investment in AI and other technologies to strengthen competitive positioning.

Opportunities:

• Expansion in the healthcare sector with a growing acceptance of the consolidated service model for pharmacy distribution.

• New market opportunities and geographic expansion, particularly in European markets.

Risks:

• The transition from license revenue to SaaS may affect growth metrics as traditional license revenue diminishes.

• Revenue from hardware expected to moderate in FY 2025, impacting overall revenue growth rates.

More details: TECSYS INC IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.